RxDoctor Payments DataLook up a doctor →

Joan Prowda

Diagnostic Radiology · Philadelphia, PANPI 1194754390

Payments from drug & device makers

$1,076,709in general payments, 2019–2025

Across 435 payments — averaging $2475.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$653K
  • Pfizer$352K
  • Astrazeneca UK Limited$46K
  • Amgen$18K
  • Eli Lilly$8K
$286,657in research payments, 2019–2025

Across 72 payments — averaging $3981.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$232K
  • E.r. Squibb & Sons, L.L.C.$35K
  • Eli Lilly$19K
  • Novartis$560

What the payments were for

  • Consulting fees$1,056,609100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck350$652,599
Pfizer61$352,255
Astrazeneca UK Limited15$45,770
Amgen8$17,705
Eli Lilly1$8,380

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,076,709 in reported general payments places this provider in the 95th percentile of 1,665 diagnostic radiology providers in Pennsylvania.

See all diagnostic radiology providers in Pennsylvania

Other diagnostic radiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →